Clinical trial
Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily…
NCT00264017 · Dattoli Cancer Center and Brachytherapy Research Institute, Other · Completed
Key facts
| NCT number | NCT00264017 |
|---|---|
| Title | Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis |
| Official title | Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs Twice Daily Dosing of Flomax-A 3 Month Retrospective Efficacy Analysis |
| Lead sponsor | Dattoli Cancer Center and Brachytherapy Research Institute, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Prostate Cancer Patients Undergoing External Radiation and Seed Implantation |
| Enrollment | 60 |
| Start date | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Dec 12, 2005 |
| Last update posted | Dec 12, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: